Literature DB >> 24014101

Plac1 (placenta-specific 1) is widely expressed during fetal development and is associated with a lethal form of hydrocephalus.

Xiaoyuan Kong1, Suzanne M Jackman, Michael E Fant.   

Abstract

BACKGROUND: Plac1 is an X-linked gene essential for normal placental development. Plac1 ablation is associated with placentomegaly and intrauterine growth retardation. Additionally, Plac1-null mice exhibit reduced postnatal viability. This study was conducted as part of our ongoing examination of the postnatal phenotype associated with Plac1 ablation.
METHODS: Plac1 was deleted in murine embryonic stem cells and bred against a C57BL/6 background. Mutant mice were genotyped using a polymerase chain reaction-based strategy. Embryonic Plac1 expression was assessed by quantitative real-time polymerase chain reaction, in situ hybridization, and β-galactosidase expression.
RESULTS: A total of 20% of the surviving X(m-)Y (knockout) males as well as 10-15% of the X(m-)X females (mutant maternal allele) developed lethal hydrocephalus at 4-8 weeks. By contrast, XX(p-) hets (paternal null allele) did not. Plac1 mRNA expression was detected in the fetal brain that markedly decreased after birth. Plac1 mRNA expression localized to the hindbrain and lateral ventricles of wild-type embryos. Additionally, Plac1 expression was observed throughout the fetus including the fetal lungs, kidney, intestine, liver, and heart. Embryonic Plac1 expression was paternally imprinted with partial escape of the paternal allele from complete inactivation. The Plac1 protein localized to the apical surface of the epithelial cells lining the developing airways of the lung and proximal renal tubules, consistent with its localization in the differentiated syncytiotrophoblast.
CONCLUSION: Plac1 is expressed in the brain in a developmentally regulated manner and its absence is linked to increased risk for hydrocephalus. It is also widely expressed in fetal tissues expanding the existing paradigm to include direct tissue-specific roles during development.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Plac1; X-Chromosome; birth defects; embryo; hydrocephalus; placenta

Mesh:

Substances:

Year:  2013        PMID: 24014101     DOI: 10.1002/bdra.23171

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  Placenta-specific protein 1 (PLAC1) expression is significantly down-regulated in preeclampsia via a hypoxia-mediated mechanism.

Authors:  Eric J Devor; Donna A Santillan; Akshaya Warrier; Sabrina M Scroggins; Mark K Santillan
Journal:  J Matern Fetal Neonatal Med       Date:  2021-09-26

Review 2.  The nexus of prematurity, birth defects, and intrauterine growth restriction: a role for plac1-regulated pathways.

Authors:  Michael E Fant; Juan Fuentes; Xiaoyuan Kong; Suzanne Jackman
Journal:  Front Pediatr       Date:  2014-02-21       Impact factor: 3.418

3.  Placenta-specific protein 1: a potential key to many oncofetal-placental OB/GYN research questions.

Authors:  Eric J Devor; Henry D Reyes; Donna A Santillan; Mark K Santillan; Chinenye Onukwugha; Michael J Goodheart; Kimberly K Leslie
Journal:  Obstet Gynecol Int       Date:  2014-03-17

4.  Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR.

Authors:  Stavros Sifakis; Vasilis P Androutsopoulos; Artemis Pontikaki; Alexis Velegrakis; George I Papaioannou; Ourania Koukoura; Demetrios A Spandidos; Nikos Papantoniou
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

5.  PLAC1 affects cell to cell communication by interacting with the desmosome complex.

Authors:  Yaohui Chen; Carole Stagg; David Schlessinger; Ramaiah Nagaraja
Journal:  Placenta       Date:  2021-06-06       Impact factor: 3.287

6.  NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.

Authors:  Meike Wagner; Michael Koslowski; Claudia Paret; Marcus Schmidt; Ozlem Türeci; Ugur Sahin
Journal:  BMC Cancer       Date:  2013-12-04       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.